APA aipamena

Choi, Y., Bocanegra, M., Kwon, M. J., Shin, Y. K., Nam, S. J., Yang, J., . . . Pollack, J. R. (2010). LYN is a mediator of epithelial-mesenchymal transition and target of dasatinib in breast cancer.

Chicago Style aipamena

Choi, Yoon-La, Melanie Bocanegra, Mi Jeong Kwon, Young Kee Shin, Seok Jin Nam, Jung-Hyun Yang, Jessica Kao, Andrew K. Godwin, and Jonathan R. Pollack. LYN Is a Mediator of Epithelial-mesenchymal Transition and Target of Dasatinib in Breast Cancer. 2010.

MLA aipamena

Choi, Yoon-La, et al. LYN Is a Mediator of Epithelial-mesenchymal Transition and Target of Dasatinib in Breast Cancer. 2010.